Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 23, 2019
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseasesSudhir Gupta, Mark Stein, Iftikhar Hussain, et al.The Turkish Journal of Pediatrics|March 25, 2011
Clinical features of chronic granulomatous disease: a series of 26 patients from a single centerTuba Turul-Ozgür, Gülten Türkkani-Asal, Ilhan Tezcan, et al.Immunotherapy|April 21, 2022
Long-term safety of facilitated subcutaneous immunoglobulin treatment in pregnant women with primary immunodeficiency diseases: results from a registry studyMichael Borte, Stefan Raffac, Martin Hrubiško, et al.The Turkish Journal of Pediatrics|October 27, 2004
Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasiaOzden Sanal, Filiz Ozbaş-Gerçeker, Leman Yel, et al.Journal of Clinical Immunology|August 1, 2002
Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneityOzden Sanal, Fúgen Ersoy, Ilhan Tezcan, et al.Molecular Immunology|November 30, 2010
Endonuclease G plays a role in immunoglobulin class switch DNA recombination by introducing double-strand breaks in switch regionsHong Zan, Jinsong Zhang, Ahmed Al-Qahtani, et al.Journal of Clinical Immunology|June 10, 2014
Autoimmunity and inflammation in X-linked agammaglobulinemiaVivian P Hernandez-Trujillo, Chris Scalchunes, Charlotte Cunningham-Rundles, et al.Immunotherapy|July 29, 2016
Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerabilityRichard L Wasserman, Isaac Melamed, Lisa Kobrynski, et al.Journal of Clinical Immunology|August 19, 2024
Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety StudyArye Rubinstein, Mohsen Mabudian, Donald McNeil, et al.Journal of Clinical Immunology|January 19, 2006
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at homeUwe Nicolay, Peter Kiessling, Melvin Berger, et al.Pageof 6